Skip to main content

Harmony Biosciences Holdings, Inc 10-Q for FY2022 Q3

Harmony Biosciences Holdings, Inc. (HRMY)

10-Q 2022-11-01 For: 2022-09-30
View Original
Added on April 04, 2026

About this 10-Q

Harmony Biosciences Holdings, Inc filed this 10-Q on November 1, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).

Headline figures

Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$117.21M
up 45.2% from $80.73M a year earlier
Net income
$87.94M
compared with a net loss of $9.62M a year earlier
Diluted EPS
$1.44
compared with -$0.17 a year earlier